BioPharma
Revolutionizing Pharma Packaging with PCR: Pros and Cons
It's important to note that pharmaceutical packing is often overlooked in the complicated world of modern healthcare. However, it is an important part of keeping vital drugs safe. Plastic has been used in this way for a long time...
BioPharma
Transforming Pharma Supply Chains with AI and ESG Practices
As a matter of fact, the pharmaceutical industry is continuously undergoing transition, and the supply chain is one of the most important aspects of this shift. There has never been a time when the importance of a supply chain...
BioPharma
Pharmaceutical Contract Sales Market to Hit $26.24B by 2034
Contract Sales Organizations: Transforming Pharma Companies
Contract sales organizations – CSOs are becoming vital tools for pharmaceutical companies to boost sales performance while keeping marketing costs low. These organizations happen to offer experts who work alongside pharmaceutical companies in order...
BioPharma
Asia-Pacific Governments Boost Healthcare Innovation And R&D
Several Asian-Pacific local governments have passed helpful policies and rules in the last five years to improve healthcare and speed up drug research in their own markets. These projects have made it much easier for people in the business...
BioPharma
Biotech Outsourcing: Trends, CDMO Growth, And Expansion
The field of biotechnology has seen tremendous evolution over the past ten years—driven by scientific advances, increasing investment, and an ever-globalized approach to innovation. And during this whole process, the outsourcing of important functions has become a key strategy for the...
BioPharma
Advancing Continuous Bioprocessing For Enhanced Productivity
The biopharmaceutical sector is now going through a significant transition toward continuous bioprocessing which is currently taking place. In contrast to the conventional batch processing method, which is characterized by the presence of distinct phases and interim holding tanks,...
BioPharma
Generative AI In Pharma: Major Opportunities And Hurdles
Among the pharmaceutical DX-digital transformation professionals, 67% responded that they were not ready when asked about how ready the life sciences sector is to effectively go ahead and leverage generative AI in terms of infrastructure, regulatory considerations, and expertise....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















